Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1501-1510 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|June 14, 2013
Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD AndersonM Othus, H Kantarjian, S Petersdorf, et al.
Leukemia|June 15, 2013
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemiaK H Metzeler, K Maharry, J Kohlschmidt, et al.
Leukemia|June 19, 2013
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenograftsV Agnusdei, S Minuzzo, C Frasson, et al.
Leukemia|February 6, 2013
AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKLM J Stankiewicz, J D Crispino
Leukemia|February 7, 2013
How to manage Waldenstrom's macroglobulinemiaC Buske, V Leblond
Leukemia|July 24, 2013
Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomibM Huang, D Thomas, M X Li, et al.
Leukemia|March 27, 2013
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplantG Weber, U Gerdemann, I Caruana, et al.
Leukemia|July 30, 2013
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potentialL M Neri, A Cani, A M Martelli, et al.
Leukemia|September 4, 2013
SP/drug efflux functionality of hematopoietic progenitors is controlled by mesenchymal niche through VLA-4/CD44 axisJ-V Malfuson, L Boutin, D Clay, et al.
Leukemia|August 6, 2013
Histone deacetylase 3 as a novel therapeutic target in multiple myelomaJ Minami, R Suzuki, R Mazitschek, et al.
Pageof 963

Showing results (1501-1510 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|June 14, 2013
Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD AndersonM Othus, H Kantarjian, S Petersdorf, et al.
Leukemia|June 15, 2013
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemiaK H Metzeler, K Maharry, J Kohlschmidt, et al.
Leukemia|June 19, 2013
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenograftsV Agnusdei, S Minuzzo, C Frasson, et al.
Leukemia|February 6, 2013
AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKLM J Stankiewicz, J D Crispino
Leukemia|February 7, 2013
How to manage Waldenstrom's macroglobulinemiaC Buske, V Leblond
Leukemia|July 24, 2013
Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomibM Huang, D Thomas, M X Li, et al.
Leukemia|March 27, 2013
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplantG Weber, U Gerdemann, I Caruana, et al.
Leukemia|July 30, 2013
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potentialL M Neri, A Cani, A M Martelli, et al.
Leukemia|September 4, 2013
SP/drug efflux functionality of hematopoietic progenitors is controlled by mesenchymal niche through VLA-4/CD44 axisJ-V Malfuson, L Boutin, D Clay, et al.
Leukemia|August 6, 2013
Histone deacetylase 3 as a novel therapeutic target in multiple myelomaJ Minami, R Suzuki, R Mazitschek, et al.
Pageof 963